EMILY FERNANDEZ-BELL: Open Payments
NPI 1295249167 · RIVERSIDE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$352 in 6 payments from 4 companies in 2025. Trend: 2023 $122 · 2024 $172 · 2025 $352
Food & beverage: $352
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 2 | $256 |
| Optinose US, Inc. | 2 | $51 |
| Organogenesis Inc. | 1 | $30 |
| GENZYME CORPORATION | 1 | $15 |
Products named: FREESTYLE LIBRE 3, Xhance, CYGNUS DUAL, DUPIXENT.
Industry payments across CA — which companies pay providers there.
